Prince Philip Hospital is a district general hospital in Llanelli, Wales. It is managed by Hywel Dda University Health Board.

During the past decade, Prince Philip Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Prince Philip Hospital" #1 sponsor was "Hywel Dda Health Board" with 3 trials, followed by "Pfizer" with 2 trials sponsored, "Bayer" with 1 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored and "Institute of Cancer Research, United Kingdom" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prince Philip Hospital" #1 collaborator was "Bevan Commission" with 1 trials as a collaborator, "Bond Digital Health Ltd." with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Memorial Sloan Kettering Cancer Center" with 1 trials as a collaborator and "Swansea University" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Prince Philip Hospital" are "Cardiovascular Disease" (2 trials), "Breast Cancer" (1 trials), "COPD" (1 trials), "Cancer" (1 trials) and "Chronic Obstructive Airway Disease" (1 trials). Many other conditions were trialed in "Prince Philip Hospital" in a lesser frequency.

Most popular intervention types in "Prince Philip Hospital" are "Drug" (7 trials), "Other" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Any LABA/LAMA" (1 trials), "Aromatase Inhibitors" (1 trials) and "COPD Pal" (1 trials). Other intervention names were less common.

The vast majority of trials in "Prince Philip Hospital" are 6 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Prince Philip Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Prince Philip Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Prince Philip Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".